all - Opinion Summaries
Page 4 of 88
Showing Result 31 - 40 of 874
| Description | Date | Docket # |
|---|---|---|
Vanda Pharmaceuticals Inc. v. West Ward PharmaceuticalsUnited States Federal Circuit
Health Law, Intellectual Property, Drugs & Biotech, PatentAffirming the decision of the district court holding, after a bench trial, that the asserted claims of a patent relating to the treatment of... |
04/13/2018 | 16-2707 |
Kader v. Sarepta Therapeutics, Inc.United States First Circuit
Drugs & Biotech, Class Actions, Securities Law, Civil ProcedureAffirming the district court dismissal of a case in which a class of purchasers of securities issued by a drug company that the investors said... |
04/04/2018 | 17-1139P.01A |
Spireas v. Commissioner of Internal RevenueUnited States Third Circuit
Tax Law, Drugs & BiotechAffirming a Tax Court determination that royalties paid on technology license agreements should be treated as ordinary income rather than as capital... |
03/26/2018 | 17-1084 |
Marentette v. Abbott Laboratories, Inc.United States Second Circuit
Drugs & Biotech, Civil Procedure, Class ActionsAffirming a district court decision holding that a putative class action suit that organic labeled baby formula included ingredients not permitted... |
03/23/2018 | 17-62 |
US v. Millennium PharmaceuticalsUnited States Ninth Circuit
Drugs & Biotech, Criminal Law & ProcedurePartly affirming, partly vacating, and remanding the district court dismissal of a False Claims Act action brought against three pharmaceutical... |
03/15/2018 | 15-16953 |
Crowley v. EpiCept CorporationUnited States Ninth Circuit
Civil Procedure, Intellectual Property, Patent, Drugs & BiotechAffirming the district court's judgment for the defense in a diversity action brought by doctors alleging claims arising from their assignment of... |
02/13/2018 | 15-56571 |
Merck Sharp and Dohme Corp. v. Amneal Pharmaceuticals LLCUnited States Federal Circuit
Intellectual Property, Patent, Drugs & BiotechAffirming the District Court's determination that a proposed generic nasal spray would not infringe the patents of a company manufacturing the Nasonex... |
02/09/2018 | 17-1560 |
The Medecines Company v. Hospira, Inc.United States Federal Circuit
Intellectual Property, Patent, Drugs & BiotechAffirming the district court's finding of noninfringement and remanding to determine whether the on-sale bar applies in a case relating to an... |
02/06/2018 | 14-1469 |
US v. StepanetsUnited States First Circuit
Drugs & Biotech, Criminal Law & ProcedureReversing and Remanding an order dismissing counts in an indictment charging three defendants involving the dispensing of misbranded drugs in... |
01/12/2018 | 16-2402P.01A |
T.H. v. Novartis Pharmaceuticals CorporationSupreme Court of California
Injury & Tort Law, Drugs & Biotech, Product LiabilityAffirming the Court of Appeals determination that the manufacturer of a name brand drug whose labeling directs the warnings provided on its generic... |
12/21/2017 | S233898 |
Results 31 to 40 of 874